<i>L</i> -Carnitine–Mediated Tumor Cell Protection and Poor Patient Survival Associated with OCTN2 Overexpression in Glioblastoma Multiforme - Concepedia

Concepedia

Publication | Closed Access

<i>L</i> -Carnitine–Mediated Tumor Cell Protection and Poor Patient Survival Associated with OCTN2 Overexpression in Glioblastoma Multiforme

51

Citations

31

References

2019

Year

Matthias A. Fink, Heiko Paland, Susann Herzog, Markus Grube, Silke Vogelgesang, Kerstin Weitmann, Angela Bialke, Wolfgang Hoffmann, Bernhard H. Rauch, Henry W. S. Schroeder,

Clinical Cancer Research

Abstract

Our data indicate a potential role of the OCTN2/LC system in GBM progression and resistance to therapy, and suggests OCTN2 as a prognostic marker in patients with primary GBM.

References

	Year	Citations

Page 1